NKT cell defects in NOD mice suggest therapeutic opportunities

Journal of Autoimmunity

Volumn 19, Issue 3, 2002, Pages 117-128

  Kukreja, Anjli ^a   Costi, Guilia ^b   Marker, John ^a   Zhang, Chen Hui ^a   Sinha, Sunil ^a   Sun, Zhong ^a   Maclaren, Noel ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Autoimmunity; NKT cells; NOD mice; T cell receptors; Tolerance

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; BCG VACCINE; CELL RECEPTOR; FREUND ADJUVANT; GALACTOSYLCERAMIDE; ROSIGLITAZONE; UNCLASSIFIED DRUG; CD1 ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL DAMAGE; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LIVER; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PANCREAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; THYMUS; ANIMAL; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; C57BL MOUSE; CELL DIVISION; CONGENIC STRAIN; EXPERIMENTAL DIABETES MELLITUS; IMMUNOLOGY; IMMUNOTHERAPY; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD1; CELL DIVISION; DIABETES MELLITUS, EXPERIMENTAL; IMMUNOTHERAPY; KILLER CELLS, NATURAL; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; MICE, CONGENIC; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; ORGAN SPECIFICITY;

EID: 0036845555     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2002.0609     Document Type: Article

References (71)

1. Maclaren N.K., Kukreja A. 2000. Type 1 Diabetes. In The Metabolic and Molecular Bases of Inherited Disease, Vol. II, 8th Edition M.D. William, S. Sly, eds. McGraw-Hill, St Louis, pp. 1471-1488
2. Atkinson M.A., Eisenbarth G.S. 2001. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 358: 221-229
3. Todd J.A., Bell J.I., McDevitt H.O. 1987. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599-604
4. Quartey-Papafio R., Lund T., Chandler P., Picard J., Ozegbe P., Day S., Hutchings P.R., O'Reilly L., Kioussis D., Simpson E. 1995. Aspartate at position 57 of nonobese diabetic I-Ag7 beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus. J. Immunol. 154: 5567-5575
5. Singer S.M., Tisch R., Yang X.D., Sytwu H.K., Liblau R., McDevitt H.O. 1998. Prevention of diabetes in NOD mice by a mutated I-Ab transgene. Diabetes 47: 1570-1577
6. Leiter E.H., Serreze D.V. 1992. Antigen presenting cells and the immunogenetics of autoimmune diabetes in NOD mice. Reg. Immunol. 4: 263-273
7. Serreze D., Gaskins H.R., Leiter E. 1993. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J. Immunol. 150: 2534-2543
8. Baxter A.G., Kinder S.J., Hammond K.J., Scollay R., Godfrey D.I. 1997. Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46: 572-582
9. Salomon B., Lenschow D.J., Rhee L., Ashourian N., Singh B., Sharpe A., Bluestone J.A. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440
10. Bendelac A., Rivera M.N., Park S.H., Roark J.H. 1997. Mouse CD1-specific NK1 T cells: Development, specificity, and function. Annu. Rev. Immunol. 15: 535-562
11. Bendelac A. 1995. Positive selection of mouse NK1 + T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182: 2091-2096
12. Kawano T., Cui J., Koezuka Y., Toura L, Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., Taniguchi M. 1997. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278: 1626-1629
13. Schofield L., McConville M.J., Hansen D., Campbell A.S., Fraser-Reid B., Brusby M.J., Tachado S.D. 1999. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 283: 225-229
14. Ohteki T., MacDonald H.R. 1994. Major histocompatibility complex class I related molecules control the development of CD4+8- and CD4-8-subsets of natural killer 1.1+ T cell receptor-alpha/beta+ cells in the liver of mice. J. Exp. Med. 180: 699-704
15. Yankelevich B., Knobloch C., Nowicki M., Dennert G. 1989. A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts. J. Immunol. 142: 3423-3430
16. Ballas Z.K., Rasmussen W. 1990. NK1.1+ thymocytes. Adult murine CD4-, CD8- thymocytes contain an NK1.1+, CD3+, CD5hi, CD44hi, TCR-V beta 8+ subset. J. Immunol. 145: 1039-1045
17. Sykes M., Hoyles K.A., Romick M.L., Sachs D.H. 1990. In vitro and in vivo analysis of bone marrow-derived CD3+, CD4-, CD8-, NK1.1+ cell lines. Cell Immunol. 129: 478-493
18. Mieza M.A., Itoh T., Cui J.Q., Makino Y., Kawano T., Tsuchida K., Koike T., Shirai T., Yagita H., Matsuzawa A., Koseki H., Taniguchi M. 1996. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 156: 4035-4040
19. Yoshimoto T., Bendelac A., Hu-Li J., Paul W.E. 1995. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4. Proc. Natl Acad. Sci. USA 92: 11931-11934
20. Gombert J.M., Herbelin A., Tancrede-Bohin E., Dy M., Carnaud C., Bach J.F. 1996. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur. J. Immunol. 26: 2989-2998
21. Laloux V., Beaudoin L., Jeske D., Carnaud C., Lehuen A. 2001. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J. Immunol. 166: 3749-3756
22. Iwakoshi N.N., Greiner D.L., Rossini A.A., Mordes J.P. 1999. Diabetes prone BB rats are severely deficient in natural killer T cells. Autoimmunity 31: 1-14
23. Wilson S.B., Kent S.C., Patton K.T., Orban T., Jackson R.A., Exley M., Porcelli S., Schatz D.A., Atkinson M.A., Balk S.P., Strominger J.L., Hafler D.A. 1998. Correction: Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391: 177-181
24. Kukreja A., Costi G., Marker J., Zhang C., Sun Z., Lin-Su K., Ten S., Sanz M., Exley M., Wilson B., Porcelli S., Maclaren N. 2002. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109: 131-140
25. Lehuen A., Lantz O., Beaudoin L., Laloux V., Carnaud C., Bendelac A., Bach J.F., Monteiro R.C. 1998. Overexpression of natural killer T cells protects Valpha14-Jalpha281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188: 1831-1839
26. Cui J., Shin T., Kawano T., Sato H., Kondo E., Toura I., Kaneko Y., Koseki H., Kanno M., Taniguchi M. 1997. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626
27. Yui M., Muralidharan K., Moreno-Altamirano B., Perrin G., Chestnut K., Wakeland E. 1995. Production of congenic mouse strains carrying NOD-derived diabetogenic genetic intervals: An approach for the genetic dissection of complex traits. Mammalian Genome 7: 331-334
28. Reifsnyder P., Flynn J., Gavin A., Simone E., Sharp J., Herberg L., Leiter E. 1998. Genotypic and phenotypic characterization of six new recombinant congenic strains derived from NOD/Shi and CBA/J genomes. Mammalian Genome 10
29. Qin H.Y., Singh B. 1997. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide. J. Autoimmun. 10: 271-278
30. Sadelain M.W., Qin H.Y., Sing B. 1990. Prevention of type 1 diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39: 583-589
31. Murray H.W., Nathan C.F. 1999. Macrophage microbicidal mechanisms in vivo: Reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med. 189: 741-746
32. Gorski J., Wassai M., Zhu X., Kissela B., Keever C., Flomenberg N. 1994. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J. Immunol. 152: 5109-5119
33. Ohteki T., Maki C., Koyasu S., Mak T.W., Ohashi P.S. 1999. Cutting edge: LFA-1 is required for liver NK1.1+TCR alpha beta+ cell development: Evidence that liver NK1.1+TCR alpha beta + cells originate from multiple pathways. J. Immunol. 162: 3753-3756
34. Staunton D.E., Dustin M.L., Springer T.A. 1989. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature 339: 61-64
35. Wang J.H., Springer T.A. 1998. Structural specializations of immunoglobulin superfamily members of adhesion to integrins and viruses. Immunol. Reviews 163: 197-215
36. Green J.M., Thompson C.B. 1994. Modulation of T cell proliferation responses by acessory cell interactions. Immunol. Research 13: 234-243
37. Naumov Y.N., Bahjat K.S., Gausling R., Abraham R., Exley M.A., Koezuka Y., Balk S.B., Strominger J.L., Clare-Salzer M., Wilson S.B. 2001. Activation of CD 1 d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl Acad. Sci. USA 98: 13838-13843
38. Aljada A., Ghanim H., Friedman J., Garg R., Mohanty P., Dadona P. 2001. Troglitazone reduces the expression of PPAR gamma while stimulating that of PPAR alpha in mononuclear cells in obese subjects. J. Clin. Endocrinol. Metab. 86: 3130-3133
39. Niino M., Iwabuchi K., Kikuchi S., Ato M., Morohashi T., Ogata A., Tashiro K., Onoe K. 2001. Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor gamma. J. Neuroimmunol. 116: 40-48
40. Chen H., Paul W.E. 1998. A population of CD62L low Nk1.1-CD4+T cells that resembles NK1.1+CD4+ T cells. Eur. J. Immunol. 25: 3172-3182
41. Eberl G., Lees R., Smiley S.T., Taniguchi M., Grusby M.J., MacDonald H.R. 1999. Tissue-specific segregation of CD Id-dependent and CD 1d-independent NK T cells. J. Immunol. 162: 6410-6419
42. Zlotnik A., Godfrey D.I., Fischer M., Suda T. 1992. Cytokine production by mature and immature CD4-CD8-T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4. J. Immunol. 149: 1211-1215
43. Carnaud C., Gombert J., Donnars O., Garchon H., Herbelin A. 2001. Protection T cell performance in NOD.NK1.1 mice congenic at the NK, complex. J. Immunol. 166: 2404-2411
44. Poulton L.D., Smyth M.J., Hawke C.G., Silveira P., Shpherd D., Naidenko O.V., Godfrey D.I., Baxter A.G. 2001. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int. Immunol. 13: 887-896
45. Hammond K.J., Pellicci D.G., Poulton L.D., Naidenko O.V., Scalzo A.A., Baxter A.G., Godfrey D.I. 2001. CD1d-restricted NKT cells: An interstrain comparison. J. Immunol. 167: 1164-1173
46. Smyth M., Godfrey D. 2000. NKT cells and tumor immunity - A double-edged sword. Nature Immunol. 1: 459-460
47. Sharif S., Arreaza G.A., Zucker P., Mi Q.S., Sondhi J., Naidenko O.V., Kronenberg M., Koezuka Y., Delovitch T.L., Gombert J.M., Leite-De-Moraes M., Gouarin C., Zhu R., Hameg A., Nakayama T., Taniguchi M., Lepault F., Lehuen A., Bach J.F., Herbelin A. 2001. Activation of natural killer T-cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nature Med. 7: 1057-1062
48. Gombert J.M., Tancrede-Bohin E., Hameg A., Leite-de-Moraes M.C., Vicari A., Bach J.F., A. H. 1996. IL-7 reverses NKI+ T cell-defective IL-4 production in the non-obese diabetic mouse. Int. Immunol. 8: 1751-1758
49. LaFace D.M., Peck A.B. 1989. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes. Diabetes 38: 894-901
50. Sato K., Ohtsuka K., Hasegawa K., Yamagiwa S., Wantanabe H., Asakura H., Abo T. 1995. Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation. J. Exp. Med. 182: 759-767
51. Ikehara S., Ohtsuki H., Good R.A., Asamoto H., Nakamura T., Sekita K., Muso E., Tochino Y., Ida T., Kuzuya H. 1985. Prevention of type I diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation. Proc. Natl Acad. Sci. USA 82: 7743-7747
52. Ikehara S., Nakamura T., Sekita K., Muso E., Yasumizu R., Ohtsuki H., Hamashima Y., Good R.A. 1987. Treatment of systemic and organ-specific autoimmune disease in mice by allogeneic bone marrow transplantation. Prog. Clin. Biol. Res. 229: 131-146
53. Crispe I.N., Dao T., Klugewitz K., Mehal W.Z.A., Metz D.P. 2000. The liver as a site of T-cell apoptosis: Graveyard, or killing field? Immunol. Rev. 174: 47-62
54. Coles M.C., Raulet D.H. 2000. NK1.1 +T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. J. Immunol. 164: 2412-2418
55. Eberl G., MacDonald H.R. 1998. Rapid death and regeneration of NKT cells in anti-CD3epsilon- or IL-12-treated mice: A major role for bone marrow in NKT cell homeostasis. Immunity 9: 345-353
56. Huang C., Springer T.A. 1995. A binding interface on the I domain of lymphocyte function-associated antigen-1 (LFA-1) required for specific interaction with intercellular adhesion molecule 1 (ICAM-1). J. Biol. Chem. 270: 19008-19016
57. Matsumoto Y., Emoto M., Usami J., Maeda K., Yoshikai Y. 1994. A protective role of extrathymic alpha beta TcR cells in the liver in primary murine salmonellosis. Immunology 81: 8-14
58. Emoto M., Mittrucker H.W., Schmits R., Mak T.W., Kaufmann S.H. 1999. Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4+NKT cells. J. Immunol. 162: 5094-5098
59. Moriyama H., Yokono K., Amano K., Nagata M., Hasegawa Y., Okamoto N., Tsukamoto K., Miki M., Yoneda R., Yagi N., Tominaga Y., Kikutani H., Hioki K., Okumura K., Yagita H., Kasuga M. 1996. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway. J. Immunol. 157: 3737-3743
60. Bertry-Coussot L., Lucas B., Danel C., Halbwachs-Mecarelli L., Bach J.F., Chatenoud L., Lemarchand P. 2002. Long-term reversal of established autoimmunity upon transient blockade of the LFA-1/intercellular adhesion molecule-1 pathway. J. Immunol. 168: 3641-3648
61. Muir A., Peck A., Clare-Salzler M., Song Y.H., Cornelius J., Luchetta R., Krischer J., Maclaren N. 1995. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon gamma transcription. J. Clin. Invest. 95: 628-634
62. Falcone M., Yeung B., Tucker L., Rodriguez E., Sarvetnick N. 1999. A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J. Exp. Med. 190: 963-972
63. Gumperz J.E., Miyake S., Yamamura T., Brenner M.B. 2002. Functionally distinct subsets of CD 1d-restricted natural killer T cells revealed by CD Id tetramer staining. J. Exp. Med. 195: 625-636
64. Lee P.T., Benlagha K., Teyton L., Bendelac A. 2002. Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 195: 637-641
65. Hong S., Wilson M.T., Serizawa I., Wu L., Singh N., Naidenko O.V., Miura T., Haba T., Scherer D.C., Wei J., Kronenberg M., Koezuka Y., Van Kaer L. 2001. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese mice. Nature Med. 7: 1057-1062
66. Boitard C., Yasunami R., Dardenne M., JF B. 1989. T cell mediated inhibition of the transfer of autoimmune diabetes in the NOD mice. J. Exp. Med. 169: 1669-1680
67. Qin H.Y., Sadelain M.W., Hitchon C., Lauzon J., Singh B. 1993. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J. Immunol. 150: 2072-2080
68. Quinones M., Ahuja S.K., Melby P.C., Pate L., Reddick R.L., Ahuja S.S. 2000. Preformed membrane-associated stores of interleukin (IL)-12 are a previously unrecognized source of bioactive IL-12 that is mobilized within minutes of contact with an intracellular parasite. J. Exp. Med. 192: 507-516
69. Maclaren N., Lan M., Coutant R., Schatz D., Silverstein J., Muir A., Clare-Salzer M., She J.X., Malone J., Crockett S., Schwartz S., Quattrin T., De Silva M., Vander Vegt P., Notkins A., Krischer J. 1999. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives. J. Autoimmun. 12: 279-287
70. Yang Y., Bao M., Yoon J.W. 2001. Intrinsic defects in the T-cell lineage results in natural killer T-cell deficiency and the development of diabetes in the nonobese diabetic mouse. Diabetes 50: 2691-2699
71. Lin-Su K., Kukreja A., Maclaren N.K. 2001. Diabetes Vaccines: A Future to Be Realized. Diabetes Technol. & Therap. 3: 451-431